Free Trial

Zevra Therapeutics (ZVRA) Insider Trading & Ownership

Zevra Therapeutics logo
$8.99 +0.02 (+0.22%)
(As of 10:31 AM ET)

Zevra Therapeutics (NASDAQ:ZVRA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.40%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$144,300.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get ZVRA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Zevra Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ZVRA Insider Buying and Selling by Quarter

Zevra Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/11/2024Corey Michael WattonDirectorBuy500$7.92$3,960.00  
7/17/2024R. Laduane CliftonCFOBuy2,000$6.77$13,540.00  
7/16/2024Thomas AndersonDirectorBuy10,000$6.81$68,100.00  
7/12/2024John B BodeDirectorBuy10,000$5.87$58,700.00  
(Data available from 1/1/2013 forward)

ZVRA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Zevra Therapeutics includes Corey Michael Watton, John B Bode, Joshua Schafer, Matthew R Plooster, R. Laduane Clifton, Richard W Pascoe, Tamara A Seymour, Thomas Anderson, and Timothy J Sangiovanni. Learn more on insiders at ZVRA.

2.40% of Zevra Therapeutics stock is owned by insiders. Learn more on ZVRA's insider holdings.

The following insiders have purchased ZVRA shares in the last 24 months: Corey Michael Watton ($9,434.25), John B Bode ($160,400.00), Joshua Schafer ($17,205.00), Matthew R Plooster ($46,200.00), R. Laduane Clifton ($39,221.75), Richard W Pascoe ($42,000.00), Tamara A Seymour ($2,501.58), Thomas Anderson ($68,100.00), and Timothy J Sangiovanni ($4,968.00).

Insiders have purchased a total of 75,184 ZVRA shares in the last 24 months for a total of $390,030.58 bought.

Zevra Therapeutics Key Executives

  • Mr. Neil F. McFarlane (Age 51)
    President, CEO & Director
    Compensation: $503.77k
  • Ms. Christal M. M. Mickle M.A. (Age 45)
    Co-Founder & Chief Development Officer
    Compensation: $622.36k
  • Mr. R. LaDuane Clifton CPA (Age 52)
    CFO, Secretary & Treasurer
    Compensation: $658.43k
    1 recent trades
  • Mr. Joshua M. Schafer M.B.A. (Age 52)
    Chief Commercial Officer & Executive VP of Business Development
    Compensation: $766.07k
  • Dr. Sven Guenther Ph.D. (Age 52)
    Chief Scientific Officer
    Compensation: $497.26k
  • Ms. Nichol L. Ochsner
    Vice President of Investor Relations & Corporate Communications
  • Mr. Rahsaan W. Thompson J.D. (Age 53)
    Chief Legal Officer, Secretary & Compliance Officer
  • Ms. Alison Peters
    Chief People Officer
  • Dr. Christopher M. Lauderback Ph.D. (Age 49)
    Senior Vice President of Manufacturing
  • Dr. Rene A. Braeckman Ph.D.
    Senior Vice President of Clinical Development


This page (NASDAQ:ZVRA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners